Turkish Validity and Reliability of the Core Lower Urinary Tract Symptoms Questionnaire in Individuals With Multiple Sclerosis
1 other identifier
observational
71
1 country
1
Brief Summary
The aim of this study is to study the validity and reliability of Core Lower Urinary Tract Symptoms Score in patients with multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2024
CompletedFirst Submitted
Initial submission to the registry
September 12, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2025
CompletedSeptember 5, 2025
August 1, 2025
8 months
September 12, 2024
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Core Lower Urinary Tract Symptoms Score
The questionnaire was developed by Homma et al. in 2008 to assess lower urinary tract symptoms. The Turkish validity and reliability study of the questionnaire was conducted by Erbay et al. in 2022. The first 5 questions in the 13-question questionnaire are about storage problems, the next 3 questions are about urination problems, and the next 2 questions are about lower urinary tract pain. The first 10 questions are scored on a Likert-type scale from 0 to 3. The Core Lower Urinary Tract also includes a question asking participants to list three core symptoms (question 11) and a question about the primary core symptom (question 12). It also includes a question about quality of life (question 13). The last question is about the patients\' satisfaction with their current urinary status, scored from 0 to 6.
10 minuttes
Secondary Outcomes (1)
Overactive Bladder Questionnaire-V8
5 minutes
Study Arms (1)
Multiple Sclerosis Group
Individuals between the ages of 18-65 who have been diagnosed with multiple sclerosis by a specialist physician.
Eligibility Criteria
Being diagnosed with multiple sclerosis by a specialist physician between the ages of 18-65.
You may qualify if:
- Being between 18-65 years old
- Being diagnosed with multiple sclerosis by a specialist
- Being willing to participate in the study
- Being literate
You may not qualify if:
- Not volunteering to participate in the study
- Having a neurological disorder that prevents speech
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kutahya Health Sciences University
Kütahya, Center, Turkey (Türkiye)
Related Publications (1)
Kiloatar H, Delibay AA, Demir CO, Ceylan D, Uysal N. Reliability and validity of the Turkish version of the core lower urinary tract symptom score in multiple sclerosis. Acta Neurol Belg. 2025 Jun;125(3):811-817. doi: 10.1007/s13760-025-02769-0. Epub 2025 Mar 26.
PMID: 40133731DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2024
First Posted
September 19, 2024
Study Start
May 15, 2024
Primary Completion
January 15, 2025
Study Completion
March 26, 2025
Last Updated
September 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share